"Intel delivered wildly inconsistent results in 2025. The company beat Q3 estimates by a stunning margin, posting $0.23 non-GAAP EPS against a $0.01 consensus. Revenue of $13.7 billion also topped the $13.4 billion estimate. But the prior quarter saw a miss, and Q4 guidance of $12.8 billion to $13.8 billion in revenue came in below Q3 actuals. That sequential decline suggests seasonal softness, though management framed it around the Altera divestiture."
"Shares have surged 47% year to date and nearly 150% over the past 12 months. The stock hit $54.35 on January 22, just below its 52-week high of $54.41. Analyst upgrades from KeyBanc and Seaport Research fueled the rally, while UBS issued a buy rating citing improving fundamentals and strong PC and server demand. But RBC Capital held at a $50 price target with a hold rating, reflecting caution after such a sharp run."
Intel produced uneven results in 2025, with a strong Q3 beat of $0.23 non-GAAP EPS versus a $0.01 consensus and $13.7 billion in revenue following a prior-quarter miss. Management guided Q4 revenue to $12.8 billion–$13.8 billion, lower than Q3 actuals and partly attributed to the Altera divestiture. Shares surged roughly 47% year to date and nearly 150% over 12 months, reaching $54.35 on January 22 amid mixed analyst reactions. Wall Street expects $12.55 billion in Q1 sales and $.05 adjusted EPS, and FY2026 projections of $.61 and $54.04 billion. Gross and operating margins and AI-related demand will be key drivers for the report.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]